100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 100010 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 100020 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 100030 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 100040 - Statement - Consolidated Statements of Stockholders' (Deficit) Equity link:presentationLink link:calculationLink link:definitionLink 100050 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 100060 - Disclosure - Nature of Operations and Liquidity link:presentationLink link:calculationLink link:definitionLink 100070 - Disclosure - Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 100080 - Disclosure - Accrued Expenses and Other Liabilities link:presentationLink link:calculationLink link:definitionLink 100090 - Disclosure - Net Loss Per Share of Common Stock link:presentationLink link:calculationLink link:definitionLink 100100 - Disclosure - Sale of Future Royalties link:presentationLink link:calculationLink link:definitionLink 100110 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 100120 - Disclosure - Stock Award Plan and Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 100130 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 100140 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 100150 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 100160 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 100170 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 100180 - Disclosure - Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 100190 - Disclosure - Accrued Expenses and Other Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 100200 - Disclosure - Net Loss Per Share of Common Stock (Tables) link:presentationLink link:calculationLink link:definitionLink 100210 - Disclosure - Sale of Future Royalties (Tables) link:presentationLink link:calculationLink link:definitionLink 100220 - Disclosure - Stock Award Plan and Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 100230 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 100240 - Disclosure - NATURE OF OPERATIONS AND LIQUIDITY - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100250 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100260 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Fair Value of Cash Equivalents and Marketable Securities Measured on Recurring Basis and Determined by Valuation Techniques (Details) link:presentationLink link:calculationLink link:definitionLink 100270 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES - Accrued Expenses and Other Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 100280 - Disclosure - NET LOSS PER SHARE OF COMMON STOCK - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100290 - Disclosure - NET LOSS PER SHARE OF COMMON STOCK - Computation of Basic and Diluted Loss Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 100300 - Disclosure - NET LOSS PER SHARE OF COMMON STOCK - Securities Excluded from Calculation of Weighted Average Shares Outstanding as their Effect is Antidilutive (Details) link:presentationLink link:calculationLink link:definitionLink 100310 - Disclosure - Sale of Future Royalties - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100320 - Disclosure - Sale of Future Royalties - Summary of Activity of the Royalty Obligation (Details) link:presentationLink link:calculationLink link:definitionLink 100330 - Disclosure - STOCKHOLDERS' EQUITY - Private Placement of Common Stock and Warrants - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100340 - Disclosure - STOCKHOLDERS' EQUITY - At-the-Market Equity Offering Program - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100350 - Disclosure - STOCKHOLDERS' EQUITY - Term Loan Warrants - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100360 - Disclosure - STOCK AWARD PLAN AND STOCK-BASED COMPENSATION - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100370 - Disclosure - STOCK AWARD PLAN AND STOCK-BASED COMPENSATION - Stock Option Activity for Employees and Non-Employees (Details) link:presentationLink link:calculationLink link:definitionLink 100380 - Disclosure - STOCK AWARD PLAN AND STOCK-BASED COMPENSATION - Summary of Assumptions Used in Black Scholes Model to Estimate Fair Value of Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 100390 - Disclosure - STOCK AWARD PLAN AND STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation Expense Included in the Company's Consolidated Statements of Operations (Details) link:presentationLink link:calculationLink link:definitionLink 100400 - Disclosure - INCOME TAXES - Schedule of Provision for Federal, Foreign and State Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 100410 - Disclosure - INCOME TAXES - Net Deferred Tax Assets (Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 100420 - Disclosure - INCOME TAXES - Schedule of Effective Income Tax Rate Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 100430 - Disclosure - INCOME TAXES - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100440 - Disclosure - COMMITMENTS AND CONTINGENCIES - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink Auditor Firm ID Auditor Firm ID Maximum percentage of common stock affiliates collectively hold Maximum Percentage Of Common Stock Affiliates Collectively Hold Maximum percentage of common stock affiliates collectively hold. Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative Document Transition Report Document Transition Report Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted-Average Remaining Contractual Term Outstanding (Years) Deferred Tax Assets, in Process Research and Development Capitalized research and development costs Performance-based restricted stock units ("PRSUs") Performance Based Restricted Stock Units [Member] Performance-based Restricted Stock Units Performance-based restricted stock units. Number of tranches. Number Of Tranches Number of tranches Lease commencement date. Lease Commencement Date Lease commencement date Costs paid in connection with private placements Costs paid in connection with private placements Offering expenses Payments of Stock Issuance Costs Disclosure of accounting policy for significant risks and uncertainties. Significant Risks And Uncertainties Policy [Text Block] Significant Risks and Uncertainties Warrants Not Settleable in Cash, Fair Value Disclosure Fair value of warrants estimated Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Vesting period of PRSUs after acceptance Sale Of Future Royalties [Abstract] Sale of future royalties. Restricted Stock Units (RSUs) [Member] Restricted Stock Units Fair Value, Inputs, Level 1 [Member] Level 1 Entity Public Float Entity Public Float Effective Income Tax Rate Reconciliation, Deduction, Percent Permanent differences Effective Income Tax Rate Reconciliation, Deduction, Percent, Total Income Tax, Policy [Policy Text Block] Income Taxes Property, Plant and Equipment, Useful Life Equipment estimated useful life Revenue from Contract with Customer, Excluding Assessed Tax Revenues from product sales to date Upfront payment paid. Upfront Payment Paid Upfront Payment Paid Upfront payment from the sale of future royalties Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Total unrecognized compensation costs Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Increase (decrease) in valuation allowance on net deferred tax assets ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Refundable regulatory fee current. Refundable regulatory fee current Refundable regulatory fee Potential future milestone payments Potential Future Milestone Payments Potential future milestone payments. Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Schedule of Stock-Based Compensation Expense Included in the Company's Consolidated Statements of Operations Monthly rental rate. Monthly Rental Rate Monthly rental rate Title of Individual [Domain] Title of Individual Subsequent Events [Text Block] Subsequent Events Open Market Sale Agreement. Open Market Sale Agreement [Member] Sales Agreement Related Party Transactions [Abstract] Annual interest rate on interest expense Annual Interest Rate On Interest Expense Annual interest rate on interest expense. Assets, Current Total current assets Liabilities and Equity Total liabilities and stockholders' (deficit) equity Entity Address, State or Province Entity Address, State or Province Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Deferred income tax provision (benefit) Issuance of common stock and warrants pursuant to a private placement Stock Issued During Period, Value, New Issues Sales of common stock, value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Outstanding at the end of the period (in shares) Outstanding at the beginning of period (in shares) PRSU'S outstanding Shares issued Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average grant date fair value per share of common stock Fair value of common stock on grant date (in dollars per share) Trading Symbol Trading Symbol Deferred Tax Assets, Net of Valuation Allowance Net deferred tax assets Common Stock, Shares, Issued Common stock, shares issued Options to purchase shares of company's common stock Represents the carrying value, as of the balance sheet date, of obligations incurred through that date and payable for research and development costs. It is used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle, if longer). Accrued Research And Development Costs And Other Expenses Current Research and development costs and other accrued expenses Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Total fair value of shares vested Notice period to change beneficial ownership limitation Notice Period To Change Beneficial Ownership Limitation Notice period to change beneficial ownership limitation. Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations [Abstract] Cash, cash equivalents, and restricted cash Cash and Cash Equivalents [Member] Cash and Cash Equivalents Operating Loss Carryforwards By Tax Authority. Operating Loss Carryforwards By Tax Authority [Domain] Operating Loss Carryforwards By Tax Authority Common Stock, Capital Shares Reserved for Future Issuance Eligible for sale of equity Foreign Currency Transactions and Translations Policy [Policy Text Block] Foreign Currency Transactions Unusual Risk or Uncertainty, Nature [Domain] Unusual Risk or Uncertainty, Nature Entity Address, City or Town Entity Address, City or Town Deferred Tax Assets, Net of Valuation Allowance [Abstract] Deferred tax assets: Loan and security agreement. Loan And Security Agreement [Member] Loan and Security Agreement Reporting Unit [Domain] Subsequent Event [Member] Subsequent Event Subsequent Event Type [Axis] Subsequent Event Type Additional Paid-in Capital [Member] Additional Paid-in Capital Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Schedule of Provision for Federal, Foreign and State Income Taxes Liabilities, Current [Abstract] Current liabilities Assets, Current [Abstract] Current assets Counterparty Name [Axis] Counterparty Name Preferred Stock, Par or Stated Value Per Share Preferred stock, par value (in dollars per share) Impairment, Long-Lived Asset, Held-for-Use Impairment of long-lived assets Impairment, Long-Lived Asset, Held-for-Use, Total Statement of Stockholders' Equity [Abstract] New Jersey Division of Taxation [Member] New jersey Additional potential milestone payments. Additional Potential Milestone Payments Additional potential milestone payments Property, Plant and Equipment, Net, Total Property, Plant and Equipment, Net Equipment, net Investment Income, Interest Investment income Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative Increase (Decrease) in Regulatory Liabilities Refundable regulatory fee Entity Central Index Key Entity Central Index Key Class of Warrant or Right, Number of Securities Called by Warrants or Rights Shares of common stock to purchase by warrant Plan Name [Domain] Plan Name Assets, Fair Value Disclosure Cash equivalents Assets, Fair Value Disclosure, Total Liability related to the sale of future royalties. Liability Related To Sale Of Future Royalties Liability related to the sale of future royalties Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Preferred Stock, Shares Outstanding, Beginning Balance Preferred Stock, Shares Outstanding, Ending Balance Current Foreign Tax Expense (Benefit) Foreign Liabilities, Current Total current liabilities Entity Tax Identification Number Entity Tax Identification Number Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Loss before income taxes Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Stock-based compensation Award Type [Axis] Award Type Class of Warrant or Right [Line Items] Class Of Warrant Or Right [Line Items] Capitalized Computer Software, Net Capitalized software, net Capitalized Computer Software, Net, Total Capitalized Computer Software, Net, Beginning Balance Capitalized Computer Software, Net, Ending Balance Plan Name [Axis] Plan Name Non-cash interest expense for the sale of future royalties Non Cash Interest Expense For The Sale Of Future Royalties Non-cash interest expense for the sale of future royalties Non-cash interest expense for the sale of future royalties Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer Collaborative revenue Assets Total assets Entity Registrant Name Entity Registrant Name Entity Registrant Name Proceeds from Issuance or Sale of Equity Net proceeds after deducting sales commissions and offering costs payable Proceeds from Issuance or Sale of Equity, Total Related Party, Type [Domain] Related Party Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit), Total Retained Earnings [Member] Accumulated Deficit Minimum [Member] Minimum [Member] Minimum Revenues Total revenues Significant Accounting Policies [Text Block] SIGNIFICANT ACCOUNTING POLICIES Equity Component [Domain] Equity Component Employee Stock Option [Member] Employee Stock Option Common Stock Options Alternative investment measurement expected term. Alternative Investment Measurement Expected Term Expected life Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss income to net cash used in operating activities: Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Weighted-Average Exercise Price Deferred tax assets deferred start up and license costs. Deferred Tax Assets Deferred Start Up And License Costs Deferred start-up and license costs Sale Of Future Royalties [Table] Sale Of Future Royalties [Table] Sale of future royalties. Entity Current Reporting Status Entity Current Reporting Status Common Stock, Shares Authorized Common stock, shares authorized Number of shares of common stock authorized Research and Development Expense Research and development Research and Development Expense, Total Fees paid in connection with the reverse stock split fractional shares Fees Paid In Connection With The Reverse Stock Split Fractional Shares Fees paid in connection with the reverse stock split fractional shares. Deferred Foreign Income Tax Expense (Benefit) Foreign Pre-funded warrants exercise price exercisable time description Pre-funded Warrants Exercise Price Exercisable Time Description Pre-funded warrants exercise price exercisable time description. Assets [Abstract] Assets Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Goodwill Revenue from Contract with Customer [Policy Text Block] Revenue Recognition Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Available for future grant (in shares) Measurement Input, Expected Term [Member] Measurement Input, Expected Term Operating Loss Carryforwards By Tax Authority. Operating Loss Carryforwards By Tax Authority [Axis] Operating Loss Carryforwards By Tax Authority Common stock; $.0001 par value; 125,000,000 shares authorized; 6,993,406 and 5,340,193 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively Common Stock, Value, Issued Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Valuation allowance Adjustments due to the rounding impact from the reverse stock split for fractional shares Adjustments to Additional Paid in Capital, Stock Split Adjustments due to the rounding impact from the reverse stock split for fractional shares Number of licenses acquired. Number Of Licenses Acquired Number of licenses acquired Current Fiscal Year End Date Current Fiscal Year End Date Share-Based Payment Arrangement, Noncash Expense Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense, Total Auditor Name Auditor Name Operating Income (Loss) Loss from operations Non-cash incremental stock-based compensation cost Share Based Goods And Services Non Cash Incremental Stock Based Compensation Cost Share based goods and services non cash incremental stock based compensation cost. Income Tax Expense (Benefit) Benefit for income taxes Total income tax provision (benefit) Effective income tax rate reconciliation at federal statutory income tax rate 1. Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate1 Federal statutory rate Research and Development Expense [Member] Research and Development Nature of Operations [Text Block] Nature of Operations and Liquidity Lessee, Leases [Policy Text Block] Leases Accounts Payable and Accrued Liabilities Disclosure [Text Block] Accrued Expenses and Other Liabilities Non-cash compensation expense Share-Based Payment Arrangement, Expense Stock based compensation expense Indefinite-Lived Intangible Assets [Axis] Indefinite-lived Intangible Assets Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Vesting percentage Measurement Input Type [Domain] Measurement Input Type Sales agreement. Sales Agreement [Member] Sales Agreement Valuation Approach and Technique [Domain] Valuation Approach and Technique Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Long-Lived Assets Vesting of performance-based restricted stock units (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Total Intrinsic Value Outstanding at the end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Total Intrinsic Value Outstanding at the begining of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract] Reconciliation of the Condensed Consolidated Statements of Cash Flows to the Condensed Consolidated Balance Sheets Exercise price of pre-funded warrants Exercise Price of Pre-funded Warrants Exercise price of pre-funded warrants. Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Earnings Per Share, Policy [Policy Text Block] Loss Per Share Expiration anniversary date of issuance. Expiration Anniversary Date Of Issuance Expiration anniversary date of issuance Sale of Stock, Price Per Share Common stock, average price per share Operating Expenses [Abstract] Expenses Long-Term Debt, Type [Domain] Long-term Debt, Type Unlimited Carryforward. Unlimited Carryforward [Member] Unlimited Carryforward Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Depreciation, Depletion and Amortization, Nonproduction, Total Entity Voluntary Filers Entity Voluntary Filers Subsequent Events [Abstract] Commitments and Contingencies Disclosure [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Granted (in shares) Shares issued Equity [Text Block] Stockholders' Equity Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Investors Investor [Member] U S Food And Drug Administration Member U S Food And Drug Administration [Member] FDA [Member] Alternative Investment, Measurement Input Alternative investment, measurement input Nature of operations and liquidity. Nature Of Operations And Liquidity [Line Items] Nature Of Operations And Liquidity [Line Items] Equity, Attributable to Parent [Abstract] Stockholders' (deficit) equity Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Line of Credit Facility, Maximum Borrowing Capacity Aggregate principal amount Deferred tax liabilities depreciation. Deferred Tax Liabilities Depreciation Depreciation Earnings Per Share [Abstract] Operating loss expiration year start. Operating Loss Expiration Year Start Operating losses, year begin to expire Indefinite-Lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name Loss Contingencies [Table] Deferred Tax Liabilities, Net Total deferred tax liabilities Deferred Tax Liabilities, Net, Total Accounting Policies [Abstract] In Process Research and Development [Member] Development-stage Proprietary Compounds Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of Credit Risk Twenty thirteen equity incentive plan. Twenty Thirteen Equity Incentive Plan [Member] 2013 Equity Incentive Plan Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Document Financial Statement Restatement Recovery Analysis [Flag] Sale Of Future Royalties [Line Items] Sale Of Future Royalties [Line Items] Sale of future royalties. Earnings Per Share, Basic Basic Earnings Per Share, Basic, Total Net loss per share, basic Commitments and Contingencies Commitments and contingencies (Note 9) Disclosure pertaining to nature of operations and liquidity. Nature Of Operations And Liquidity [Table] Nature Of Operations And Liquidity [Table] Income Statement [Abstract] Related Party, Type [Axis] Related Party Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Interest or penalties related to income taxes Interest and penalties recognized Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense, Total Lease description. Lease Description Lease description Measurement Input Type [Axis] Measurement Input Type PRSU'S vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Statistical Measurement [Domain] Statistical Measurement Loss Contingencies [Line Items] Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net cash used in operating activities Gross proceeds from issuance of private placement Gross Proceeds From Issuance Of Private Placement Gross proceeds from issuance of private placement. All Award Types Award Type Document Period End Date Document Period End Date Statistical Measurement [Axis] Statistical Measurement Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Stockholders' Equity Note [Abstract] Unusual Risk or Uncertainty, Nature [Axis] Unusual Risk or Uncertainty, Nature Earnings Per Share, Diluted Diluted Earnings Per Share, Diluted, Total Net loss per share, diluted Regus. Regus [Member] Regus Product and Service [Domain] Product and Service Measurement Input, Expected Dividend Payment [Member] Measurement Input, Expected Dividend Payment Deferred Tax Assets, Operating Loss Carryforwards Net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards, Total Unrecognized Tax Benefits Unrecognized tax benefits, liability Unrecognized Tax Benefits, Beginning Balance Unrecognized Tax Benefits, Ending Balance Internal Revenue Service (IRS) [Member] Federal Stock option awards. Stock Option Awards Member Stock Option Awards Debt Instrument, Name [Domain] Debt Instrument, Name Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Exercisable at the end of the period (in shares) Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Related Party Transaction [Domain] Term A loans. Term A Loans [Member] Term A Loans Warrants Not Setteleable Cash . Warrants Not Settleable Cash [Member] Warrant Additional Paid in Capital, Common Stock Additional paid-in capital Summary of Activity of the Royalty Obligation Summary Of Activity Of The Royalty Obligation Table [Text Block] Summary of activity of the royalty obligation. Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Shares Issuable Pursuant to Stock Options Deferred Tax Assets, Net Total Deferred Tax Assets, Net, Total Gain (Loss), Foreign Currency Transaction, before Tax Foreign exchange losses Foreign Currency Transaction Gain (Loss), before Tax, Total Up front payment Upfront payment. Upfront Payment Upfront payment for royalty interest sold Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Exercise of stock options (in shares) Exercised (in shares) Consolidation, Policy [Policy Text Block] Consolidation Refundable regulatory fee policy. Refundable regulatory fee Policy Text Block Refundable regulatory fee Liabilities and Equity [Abstract] Liabilities and Stockholders' (Deficit) Equity Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Interactive Data Current Entity Interactive Data Current Private Placement Private Placement [Member] CARES Act . Coronavirus Aid Relief And Economic Security Act [Member] CARES Act Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Accounts Payable, Total Credit Facility [Domain] Credit Facility Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Significant accounting policies. Significant Accounting Policies [Line Items] Significant Accounting Policies [Line Items] Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Exercised (in dollars per share) Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Equity Components [Axis] Equity Components Local Phone Number Local Phone Number Sale of Stock [Axis] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Exercisable at the end of the period (in dollars per share) Current Federal Tax Expense (Benefit) Federal Research Tax Credit Carryforward [Member] Federal research and development Goodwill Goodwill Goodwill, Total Goodwill, Beginning Balance Goodwill, Ending Balance Restricted Cash, Current Restricted cash Restricted cash balances as collateral for corporate credit cards Statement of Cash Flows [Abstract] Comprehensive Income, Policy [Policy Text Block] Comprehensive Loss Tax credit carry forward expiration year. Tax Credit Carry Forward Expiration Year Federal research and development credits expiration year Property, Plant and Equipment, Policy [Policy Text Block] Equipment Document Annual Report Document Annual Report Accounts Payable and Other Accrued Liabilities, Current Accrued expenses and other current liabilities Accrued expenses and other current liabilities Common Stock, Par or Stated Value Per Share Common stock, par value (in dollars per share) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Weighted-average period over which unrecognized compensation costs is expected to be recognized Cash, cash equivalents, restricted cash and marketable securities. Cash Cash Equivalents Restricted Cash And Marketable Securities Cash, cash equivalents, restricted cash and marketable securities Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Maximum Maximum [Member] Maximum [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights Description of vesting rights Proceeds from sales of common stock and warrants in private placement Net proceeds from issuance of private placement Proceeds from Issuance of Private Placement Related Party Transaction [Axis] Fair Value, Inputs, Level 3 [Member] Level 3 APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total Fair Value, Recurring and Nonrecurring [Table] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Net increase (decrease) in cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Payables and Accruals [Abstract] Internal Use Software, Policy [Policy Text Block] Software General and Administrative Expense [Member] General and Administrative Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Cancelled/Forfeited (in shares) PRSU'S cancelled Document Financial Statement Error Correction [Flag] Reporting Unit [Axis] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Securities Excluded from Calculation of Weighted Average Shares Outstanding as their Effect is Antidilutive City Area Code City Area Code Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Research and Development Arrangement, Contract to Perform for Others, Type Deferred State and Local Income Tax Expense (Benefit) State Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows from operating activities: Seltorexant. Seltorexant [Member] Seltorexant Sale of Stock, Transaction Date Sale of stock issue date Single reporting unit. Single Reporting Unit [Member] Single Reporting Unit Costs related to issuance of common stock and warrants Adjustments To Additional Paid In Capital Costs Earnings Related To Stock And Warrants Issuance Adjustments to additional paid in capital costs earnings related to stock and warrants issuance. General and Administrative Expense General and administrative General and Administrative Expense, Total Weighted Average Number of Shares Outstanding, Basic Weighted average shares outstanding, basic Weighted average shares of common stock outstanding - basic Weighted Average Number of Shares Outstanding, Basic, Total Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Research and Development Arrangement, Contract to Perform for Others, Type Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows from financing activities: Research and Development Expense, Policy [Policy Text Block] Research and Development Costs Statement [Table] Statement [Table] Share-Based Payment Arrangement, Option, Activity [Table Text Block] Schedule of Stock Option Activity for Employees and Non-Employees Deferred tax assets sale of royalties. Deferred Tax Assets Sale Of Royalties Sale of royalties Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Summary of Assumptions Used in Black Scholes Model to Estimate Fair Value of Stock Options Document Fiscal Period Focus Document Fiscal Period Focus Related Party Transactions Disclosure [Text Block] Related Party Transactions Accrued Professional Fees, Current Professional fees Statement [Line Items] Statement [Line Items] Nature Of Operations And Liquidity Disclosure Abstract Nature Of Operations And Liquidity Disclosure [Abstract] Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Securities outstanding excluded from the calculation of weighted average shares outstanding Employees and non-employees stock option. Employees And Non Employees Stock Option [Member] Employees and Non-Employees Stock Option Non-cash interest expense associated with the sale of future royalties Non Cash Interest Expense For Sale Of Future Royalties Amount of non-cash interest expense associated with the sale of future royalties. Warrant [Member] Common Stock Warrants Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of Deferred Tax Assets and Liabilities User fees paid. User Fees Paid User fees paid, related to roluperidone Common Stock [Member] Common Stock Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value, Total Measurement Input, Risk Free Interest Rate [Member] Measurement Input, Risk Free Interest Rate Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Total Intrinsic Value Exercisable Prepaid Expense, Current Prepaid expenses and other current assets Prepaid Expense, Current, Total Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Sale of Future Royalties Sale Of Future Royalties Disclosure [Text Block] Sale of future royalties. Fair Value of Financial Instruments, Policy [Policy Text Block] Fair Value of Financial Instruments Antidilutive Securities, Name [Domain] Antidilutive Securities, Name Cover [Abstract] Potential Milestone Payments Additional milestone payments Potential Milestone Payments Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Current income tax provision (benefit) Document Fiscal Year Focus Document Fiscal Year Focus Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Interest and penalties accrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total Sale of Stock [Domain] Royalty Pharma member. Royalty Pharma [Member] Royalty Pharma Share-Based Payment Arrangement [Policy Text Block] Stock-Based Compensation Security Exchange Name Security Exchange Name Valuation Technique, Option Pricing Model [Member] Valuation Technique, Option Pricing Model Increase decrease in prepaid expense other current assets. Increase Decrease In Prepaid Expense Other Current Assets Prepaid expenses and other current assets Preferred Stock, Shares Issued Preferred stock, shares issued Preferred Stock, Shares Authorized Preferred stock, shares authorized Notes Payable to Banks [Member] Term Loan Current State and Local Tax Expense (Benefit) State Impairment Of Intangible Asset Indefinite Lived Excluding Goodwill Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag Impairment of intangible asset indefinite lived excluding goodwill statement of income or comprehensive income extensible enumeration not disclosed flag. Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Cancelled/forfeited(in dollars per share) Class of Warrant or Right [Table] Class Of Warrant Or Right [Table] Stock Issued During Period, Value, Stock Options Exercised Exercise of stock options Entity Emerging Growth Company Entity Emerging Growth Company Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Total intrinsic value of the stock options exercised Amendment Flag Amendment Flag Vesting of performance-based restricted stock units Stock Issued During Period, Value, Restricted Stock Award, Gross Tax Credit Carryforward, Amount Federal research and development credits Schedule of Accrued Liabilities [Table Text Block] Schedule of Accrued Expenses and Other Liabilities Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Deferred Tax Liabilities, Gross [Abstract] Deferred tax liabilities: Securities Act File Number Entity File Number Deferred Tax Assets, Gross Total deferred tax assets Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Total cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Beginning Balance Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Ending Balance Share-Based Payment Arrangement [Abstract] Accounts Payable, Current Accounts payable Accounts Payable, Current, Total Debt Instrument [Axis] Debt Instrument Deferred Tax Assets, Valuation Allowance Deferred tax asset valuation allowance Incremental Non-cash Compensation Cost Incremental non-cash compensation cost Incremental Non-cash Compensation Cost Incremental Non-cash Compensation Cost Operating Expenses Total expenses Capitalized Computer Software, Amortization Amortization of capitalized software Auditor Location Auditor Location Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Expected term (years) Collaborative Arrangement [Member] Collaborative Arrangement Stockholders' Equity, Reverse Stock Split Reverse stock split Preferred stock; $.0001 par value; 100,000,000 shares authorized; none issued or outstanding as of December 31, 2023 and 2022, respectively Preferred Stock, Value, Issued Entity Small Business Entity Small Business Entity Shell Company Entity Shell Company Number of Operating Segments Number of operating segments Title of Individual [Axis] Title of Individual Investment Type [Axis] Investment Type Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price Exercise price per unit Class of Warrant or Right, Exercise Price of Warrants or Rights Common stock exercise price per share Accrued Bonuses, Current Accrued bonus Earnings Per Share [Text Block] Net Loss Per Share of Common Stock Revenues [Abstract] Revenues Securities Purchase Agreement Securities Purchase Agreement [Member] Securities purchase agreement. Alternative investment measurement expected dividend payments. Alternative Investment Measurement Expected Dividend Payments Expected dividend Entity Address, Address Line One Entity Address, Address Line One Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Antidilutive Securities [Axis] Antidilutive Securities Measurement Input, Price Volatility [Member] Measurement Input, Price Volatility Subsequent Event Type [Domain] Subsequent Event Type Income Statement Location [Axis] Income Statement Location Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill) Impairment of in-process research and development Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Dividend yield Dividend yield (as a percent) Long-Term Debt, Type [Axis] Long-term Debt, Type Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total Net loss Fair Value, Inputs, Level 2 [Member] Level 2 Minimum market value of listed securities required for continued listing. Minimum Market Value of Listed Securities Required for Continued Listing Minimum market value of listed securities required for continued listing Product and Service [Axis] Product and Service Title of 12(b) Security Title of 12(b) Security Income Tax Authority, Name [Axis] Income Tax Authority, Name Fair Value, Assets Measured on Recurring Basis [Table Text Block] Fair Value of Cash Equivalents and Marketable Securities Measured on Recurring Basis and Determined by Valuation Techniques Investments [Domain] Investments Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows from investing activities: Goodwill, Impairment Loss Impairment of goodwill Segment Reporting, Policy [Policy Text Block] Segment Information Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Restricted Cash Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Weighted-Average Remaining Contractual Term Exercisable (Years) Loss Contingency [Abstract] Significant accounting policies. Significant Accounting Policies [Table] Significant Accounting Policies [Table] Common Stock, Shares, Outstanding Balance (in shares) Balance (in shares) Common stock, shares outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk free interest rate Share-Based Payment Arrangement [Text Block] Stock Award Plan and Stock-Based Compensation Tax Credit Carryforward [Axis] Tax Credit Carryforward Liability Related To The Sale Of Future Royalties Policy Text Block Liability Related To The Sale Of Future Royalties Policy [Text Block] Liability Related To The Sale Of Future Royalties Income Statement Location [Domain] Income Statement Location Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Granted (in dollars per share) Relief package. Relief Package Relief package Document Type Document Type Net Cash Provided by (Used in) Investing Activities Net cash used in investing activities Counterparty Name [Domain] Counterparty Name Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs In-process research and development Deferred Tax Liabilities, Other Other Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities President [Member] Rick Russell Entity Filer Category Entity Filer Category Deferred Tax Assets, Tax Credit Carryforwards, Research Research and development tax credits Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Expired (in dollar per share) Pre-funded warrants issuable nominal consideration per share Pre-Funded Warrants Issuable Nominal Consideration Per Share Pre-funded warrants issuable nominal consideration per share. Increase (Decrease) in Accrued Liabilities Accrued expenses and other current liabilities Increase (Decrease) in Accrued Liabilities, Total Income Tax Authority, Name [Domain] Income Tax Authority, Name Liabilities Total liabilities Reverse Stock Split [Policy Text Block] Reverse Stock Split [Policy Text Block] Reverse Stock Split MASSACHUSETTS Massachusetts Equity, Attributable to Parent Balance Balance Total stockholders' (deficit) equity Documents Incorporated by Reference [Text Block] Documents Incorporated by Reference Stock Issued During Period, Shares, Reverse Stock Splits Outstanding shares of common stock reverse stock splits Adjustments due to the rounding impact from the reverse stock split for fractional shares (in shares) Net Income (Loss) Net loss Net loss Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent State income taxes, net of federal benefit Statement of Financial Position [Abstract] Area of Real Estate Property Sublease rentable square feet Lease rentable square feet Weighted Average Number of Shares Outstanding, Diluted Weighted average shares outstanding, diluted Weighted average shares of common stock outstanding - diluted Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Schedule of Effective Income Tax Rate Reconciliation Credit Facility [Axis] Credit Facility Purchase price per share Shares Issued, Price Per Share Effective Income Tax Rate Reconciliation, Percent Effective tax rate Deferred Federal Income Tax Expense (Benefit) Federal In Process Research and Development, Policy [Policy Text Block] In-Process Research and Development Maximum beneficial ownership limitation Maximum Beneficial Ownership Limitation Maximum beneficial ownership limitation. Use of Estimates, Policy [Policy Text Block] Use of Estimates Income Tax Disclosure [Text Block] Income Taxes Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Outstanding at the end of the period (in dollars per share) Outstanding at the beginning of period (in dollars per share) Common Stock Exchanged For P R S U S Common stock exchanged for PRSUs Common Stock Exchanged For P R S U S Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Computation of Basic and Diluted Loss Per Share Valuation Approach and Technique [Axis] Valuation Approach and Technique Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Liability related to the sale of future royalties Liability Related To The Sale Of Future Royalties Liability related to the sale of future royalties. Fair Value Disclosures [Abstract] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV Payments to Acquire Property, Plant, and Equipment, Total Payments to Acquire Property, Plant, and Equipment Purchases of equipment MIN 301 Member. M I N301 [Member] MIN-301 Issuance of common stock and warrants pursuant to a private placement (in shares) Stock Issued During Period, Shares, New Issues Common stock issued and sold Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations End of period Beginning of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total Income Tax Disclosure [Abstract] Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward, Name Option Exchange Program [Member] Option Exchange Program [Member] Option exchange program. Operating Loss Carryforwards Net operating losses